FINWIRES · TerminalLIVE
FINWIRES

BMO Capital Downgrades BioNTech to Market Perform From Outperform, Adjusts PT to $105 From $128

By

BioNTech SE (BNTX) has an average rating of overweight and mean price target of $119.05, according to analysts polled by FactSet.

What else is happening in Research?